GLP‐1RAs and cardiovascular risk in HS: concerns about follow‐up time and effect estimates
Journal of the European Academy of Dermatology and Venereology · 2026-08 · 40 (8)
DOI: 10.1111/jdv.70227 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 04.12.2025. Verfasst von Beata Jastrząb und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Venereology and Clinical Immunology, Faculty of Medicine, Wroclaw University of Science and Technology, Wroclaw, Poland. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Data sharing is not applicable to this article as no new data were created or analysed in this study.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Dermatology, Venereology and Clinical Immunology, Faculty of Medicine, Wroclaw University of Science and Technology, Wroclaw, Poland.
- Department of Dermato-Venereology, 4th Military Hospital, Wroclaw, Poland.
- Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
ORCID-Profile: Piotr K Krajewski
Zitieren
APA
Jastrząb, B., & Krajewski, P. K. (2026). GLP‐1RAs and cardiovascular risk in HS: concerns about follow‐up time and effect estimates. Journal of the European Academy of Dermatology and Venereology, 40(8). https://doi.org/10.1111/jdv.70227
Vancouver
Jastrząb B, Krajewski PK. GLP‐1RAs and cardiovascular risk in HS: concerns about follow‐up time and effect estimates. Journal of the European Academy of Dermatology and Venereology. 2026;40(8). doi:10.1111/jdv.70227
BibTeX
@article{Jastrzb2026,
author = {Jastrząb, Beata and Krajewski, Piotr K},
title = {GLP‐1RAs and cardiovascular risk in HS: concerns about follow‐up time and effect estimates},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2026},
volume = {40},
number = {8},
doi = {10.1111/jdv.70227}
}
EUVIMED